Search

Your search keyword '"Joan Merrill"' showing total 3 results
Start Over Author "Joan Merrill" Journal lupus science and medicine
3 results on '"Joan Merrill"'

2. 103 Exploratory segregation of patients upon their levels of anti- mitochondrial antibodies (AMAs) reveals associations between AMAs and disease manifestations

Author

Michelle Petri, Kenneth Kalunian, Susan Manzi, Cynthia Aranow, Ellen Ginzler, Jill Buyon, Rosalind Ramsey-Goldman, Anca Askanase, Ian N Bruce, Guillermo Ruiz-Irastorza, Juanita Romero-Diaz, Caroline Gordon, Sang-Cheol Bae, Anisur Rahman, Mary Anne Dooley, Paul R Fortin, Andreas Jönsen, Sam Lim, Murat Inanc, Søren Jacobsen, Jorge Sanchez-Guerrero, Eric Boilard, Dafna Gladman, Murray Urowitz, David Isenberg, Ann E Clarke, Sasha Bernatsky, Graciela Alarcon, Christian Lood, Ronald van Vollenhoven, John Hanly, Joan Merrill, Daniel Wallace, Tania Levesque, Christine Peschken, Anne-Sophie Julien, Diane Kamen, Emmanuelle Rollet-Labelle, Yann LC Becker, and Joannie Leclerc

Subjects
Immunologic diseases. Allergy, RC581-607
Published
2022
Full Text
View/download PDF

3. Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort

Author

Manuel Francisco Ugarte-Gil, Graciela Alarcon, Risto Alfredo Perich-Campos, Claudia Elera-Fitzcarrald, Cristina Reátegui-Sokolova, Rocio Violeta Gamboa-Cardenas, Victor Román Pimentel-Quiroz, Zoila Rodriguez-Bellido, Cesar Augusto Pastor-Asurza, Anca D Askanase, Paola Zeña-Huancas, Samira Garcia-Hirsh, Luciana Gil, and Joan Merrill

Subjects
Immunologic diseases. Allergy, RC581-607
Abstract

Objective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) clinician-reported outcome (ClinRO) and the LFA-REAL patient-reported outcome (PRO) were developed in order to capture manifestations of SLE from the perspective of both the clinician and the patient. The aim of this study is to compare the LFA-REAL ClinRO and PRO with other lupus disease activity measures.Methods A cross-sectional analysis of patients from a single-centre cohort was performed using Spearman’s correlation. Disease activity measures included were LFA-REAL ClinRO (range 0–1400), LFA-REAL PRO (range 0–1200), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), clinical SLEDAI-2K and Physician Global Assessment (PGA, range 0–100).Results Two hundred and twenty-seven patients with SLE were studied. The mean age was 46.3 (SD: 13.8); 212 (93.4%) were female. The mean (SD) LFA-REAL ClinRO was 25.4 (34.7), LFA-REAL PRO was 241.1 (187.6), PGA was 11.9 (15.4), SLEDAI-2K was 2.3 (3.3) and clinical SLEDAI-2K was 1.6 (2.9). The LFA-REAL ClinRO correlated with PGA (r=0.758, p

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results